
Wild bat encounter leaves woman with $35K medical bill after insurance missteps
The bat flew away, leaving Kahn shaken.
She didn't think the animal had bitten her.
Regardless, her father, who is a physician and was travelling with her, said she should go to a hospital within a day or so and begin vaccinations against rabies.
Figuring she would be covered as long as she obtained insurance before going to the hospital, Kahn said, she found a policy online the day after the bat incident.
She said she called the company before she bought its policy and was told that services related to an accident or 'life-threatening' emergency would be covered.
Kahn went the next day to a hospital in Flagstaff, Arizona, where she started rabies prevention treatment. Over the next two weeks, she received the rest of the rabies shots at clinics in Arizona and Massachusetts and at a hospital in Colorado.
Then the bills came.
The medical procedure
Kahn received a total of four doses of the rabies vaccine. The doses are administered over the course of 14 days. With her first vaccination, she received three shots of immunoglobulin, which boosts antibodies against the virus.
Rabies is typically transmitted through bites or scratches from an infected animal.
Experts recommend precautionary measures when a person has been potentially exposed to rabies, because once the neurological disease causes symptoms, it is fatal.
The Centres for Disease Control and Prevention says post-exposure rabies treatment has reduced the number of human fatalities to fewer than 10 per year in the US.
The final bill
According to explanation-of-benefits statements, Kahn owed a total of US$20,749 ($35,216) for her care at the four facilities.
Most of the charges were from the hospital where she was first treated, Flagstaff Medical Centre: $17,079, including $15,242 for the rabies and immunoglobulin shots.
Flagstaff Medical Centre where Kahn's insurance policy didn't cover the costs due to a waiting period not being met.
The billing problem
Kahn's policy did not pay for any of the services.
'The required waiting period for this service has not been met,' said an explanation-of-benefits letter she received in December.
Kahn was stunned. 'I thought it must have been a mistake,' she said. 'I guess I was naive.'
When Kahn was laid off from her job as a biomedical engineer last summer, she had the option to temporarily stay on her former employer's insurance under a Cobra plan, at a cost of about US$650 per month.
As a young, healthy person, she gambled that she could get by without insurance until she found another job. She figured that if she needed medical care, she could quickly buy a private policy.
According to the Centres for Medicare and Medicaid Services, those who qualify for Cobra must be given at least 60 days to sign up – and if they do, the coverage applies retroactively.
Kahn, who was still within that period at the time of the incident, said recently that she did not realise she had that option.
The policy she purchased after the bat episode, which cost about US$311 a month, was from a Florida company called Innovative Partners LP.
Documents Kahn provided to KFF Health News say the policy has a 30-day waiting period, which 'does not apply to benefits regarding an accident or loss of life'.
Kahn said that after receiving notice that her claims were denied, she called the company to ask how she could appeal and was told that a doctor would have to file paperwork.
She said she wrote a letter that was signed by a doctor at Flagstaff Medical Centre and submitted it in March but was unable to reach doctors at the other facilities.
Kahn said she was given conflicting answers about where to send the paperwork. She said a representative with the company recently told her that it had not received any appeals from her.
Benefits statements Kahn received in early July show Innovative Partners LP had not paid the claims. The company did not respond to requests for comment.
Sabrina Corlette, co-director of the Centre on Health Insurance Reforms at Georgetown University, said most health coverage plans take effect on the first day of the month after a customer enrols.
'The insurance companies – for good reason – don't want people to wait to sign up for coverage until they are sick,' she said, noting the premiums healthy people pay help balance the costs of paying for healthcare.
The Affordable Care Act requires insurers to cover pre-existing conditions, such as diabetes or heart issues. But that doesn't mean they have to pay for treatment of an injury sustained shortly before a person enrols in coverage, she said.
Corlette, who reviewed a brief benefits overview provided by Kahn, said the policy appears to have been a limited, 'fixed indemnity' plan, which would pay only set amounts towards treatments per day or another period regardless of total expenses incurred. Such plans have been around for decades and aren't required to meet ACA standards, she said.
But she said even if Kahn had bought comprehensive health insurance, it probably wouldn't have covered treatment received so soon after she had purchased it.
David Shlim, a travel medicine specialist in Wyoming who studies rabies, said Kahn made the right choice by promptly seeking treatment, even though she didn't feel the bat bite her.
The disease is deadly, and the fact that the bat went into her mouth meant she could have been infected from its saliva, he said: 'You could hardly have a more direct exposure than that.'
Shlim, who recently co-wrote a federal advisory about rabies prevention, added that healthy bats don't normally fly into people, as the one in this case did. The animal's entanglement with Kahn suggests that it could have been sick, possibly with rabies, he said.
Rabies prevention treatment is much more expensive in the US than in most other countries, Shlim said. The priciest part is immunoglobulin, which is made from the blood plasma of people who have been vaccinated against rabies.
The treatment is often administered in hospital emergency rooms, which add their own steep charges, Shlim noted.
Kahn's bat incident shines a spotlight on insurance pitfalls.
The resolution
Kahn said she is employed again and has good health insurance but is still facing most of the bills from her misadventure at Glen Canyon.
She said she paid a doctor bill from Flagstaff Medical Centre after negotiating it down from US$706 to US$420. She said she has also arranged a US$10-a-month plan to pay off the US$530 she owes for one of her rabies shots at another facility.
She said she plans to continue appealing the denials of payment for the rest of the bills, which total more than US$19,000.
In a statement on behalf of the Flagstaff hospital – where Kahn incurred the highest charges – Lauren Silverstein, a spokesperson at Northern Arizona Healthcare, said that the health system does what it can to limit costs.
'We have less ability to control the prices of critical supplies that we use to treat patients, including pharmaceuticals, biologics, diagnostics, and medical devices made by other companies,' she said.
Silverstein said the hospital needs to keep immunoglobulin on hand to prevent rabies, even though such cases are relatively rare and the drug is expensive.
The takeaway
Cobra insurance policies, named for the Consolidated Omnibus Budget Reconciliation Act of 1985, enable many people who lose job-based coverage to pay to stay on those plans temporarily.
There is a 60-day window to choose Cobra coverage, and once a beneficiary pays for it, the coverage applies retroactively – meaning that medical care is covered even if it occurred when the person was uninsured.
Corlette said Kahn's predicament illustrates why people need to make sure they have health insurance.
She said people who lose employer-based coverage should consider enrolling in individual insurance plans sold on federal or state marketplaces. Many people who buy such policies qualify for substantial ACA subsidies to help pay premiums and other costs.
'If you are losing your job, Cobra is not your only option,' Corlette said.
Kahn wishes she had signed up for insurance coverage when she was laid off, even though she felt confident that she would find another job within a few months.
'That's a very big lesson I learned the hard way,' she said.
Her wildlife encounter did not destroy her love of the outdoors. She even sees humour in it.
'I know what bats taste like now. It's an earthy, sweet kind of flavour,' she joked.
'It's actually a pretty funny story – if it weren't for the horrible medical bill that came with it.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Coinbase stock hit with analyst downgrade citing 'limited support' for current valuation
Coinbase (COIN) got downgraded by analysts at Compass Point who questioned whether its valuation was sustainable. The analysts changed Coinbase's rating to Sell from Neutral and lowered its price target to $248 from $330 per share. The new price target represents a 21% decline from Friday's close. "While we remain constructive on the current crypto cycle, we expect a choppy 3Q alongside weak August/September seasonality and waning retail interest in crypto treasury stocks," Compass Point analyst Ed Engel wrote on Sunday night. "As such, we see limited support for COIN's valuation if crypto markets sell off further," he noted. The development comes after the crypto platform's stock plunged 14% on Friday, its biggest intraday drop since April, after the company's quarterly earnings report showed that revenue last quarter took a hit from lower trading volume. Compass Point pointed to Coinbase's Subscription & Services (S&S) revenue, which came in at $655.8 million versus Wall Street estimates for $715.2 million. S&S includes plans such as Coinbase One, a monthly subscription product that offers no trading fees and other perks "Investors place a higher premium on these recurring fees, thus disappointing S&S fees have a more pronounced impact on COIN's valuation," Engel wrote. The analyst also pointed out that increasing stablecoin competition will likely put downward pressure on the valuation for Coinbase and its partner, Circle (CRCL). Read more: Can you buy crypto with a credit card? See the pros and cons. The issuer of digital tokens backed by the US dollar shares part of its interest income revenue with Coinbase. Engel and his team also said they believe interest in crypto treasury stocks such as Strategy (MSTR), the largest public holder of bitcoin, is declining, limiting the ability for companies to raise money for more token purchases, essentially crypto's upside in the near term. The analyst noted Strategy has recently slowed purchases of bitcoin. "With Strategy buying $18bn BTC YTD, MSTR's pivot removes another layer of BTC buying pressure," Engel said. Not all analysts are so bearish. The stock has 19 analyst Buy recommendations, 16 Hold, and 5 Sell, according to Bloomberg data. Bernstein analysts recently dubbed Coinbase a "one-stop Amazon" of crypto services. In a note last week, the analysts reaffirmed an Outperform rating on the stock with a $510 price target. Instead, the analysts said investors should focus on crypto derivatives and the company's "everything exchange" vision for the platform. On the company's earnings call, CEO Brian Armstrong highlighted Coinbase's focus on tokenized equities, or digital tokens representing real-world stocks. "We believe tokenized equities are more efficient with global coverage, 24/7 trading, instant settlement, and the ability to offer perpetual futures," Armstrong told analysts. Year to date, Coinbase shares are up roughly 24%.Ines Ferre is a senior business reporter for Yahoo Finance. Follow her on X at @ines_ferre. Click here for in-depth analysis of the latest stock market news and events moving stock prices
Yahoo
11 minutes ago
- Yahoo
The jobs data revisions that cost a US government statistician her job
(Reuters) -The revisions to previous estimates of the size of U.S. payrolls gains for May and June that prompted President Donald Trump to fire Bureau of Labor Statistics Commissioner Erika McEntarfer on Friday were by any measure extraordinarily large. Indeed, the combined downward revision for the two months of 258,000 was the largest - outside of those during the early months of the COVID-19 pandemic - since at least 1979. Here's a quick graphical breakdown: FIRST REVISION The monthly nonfarm payrolls report, released typically on the first Friday of each month, includes an initial estimate of employment changes for the immediately preceding month and revisions to the earlier estimates for the prior two months. BLS makes the revisions because more survey responses come in over the ensuing weeks and because it updates the seasonal factors affecting each month's estimates. The BLS on Friday said 133,000 fewer jobs had been created in June than first estimated. Over the last several years, the first estimate of the net change in payrolls each month has been revised lower more often than not. It has been revised down in eight of the last 12 BLS reports over the last year. The downward revision on Friday was the largest since the first estimate of payrolls gains for March 2021, published in April 2021, was revised down by 146,000 a month later. Over the last three years through June, the median estimate revision was -10,000. That contrasts with a median increase of 8,000 during the decade before the pandemic and a median increase of 2,000 over the series history since 1979. SECOND REVISION The total for May's payroll gains was revised lower by 125,000 in Friday's report, when the third estimate for payrolls for that month was published. That figure was the largest downward reduction of payrolls gains for a second revision - outside of the pandemic era - since the estimate for March 1983 was revised down by 127,000 in the report published in June 1983. COMBINED REVISION The combined downward revision for the two previous months - May and June - was larger than anything reported outside of the pandemic era. Indeed, the estimates for the two prior months combined have more often than not been revised higher. Since 1979, the median two-month combined estimate change was an upward revision of 10,000. Measured in absolute terms - revisions in either direction - Friday's revision also stands out. There have only been four larger revisions: +709,000 for November and December 2021; -642,000 for March and April 2020; +285,000 for August and September 1983; and +414,000 for April and May 1981. Solve the daily Crossword
Yahoo
11 minutes ago
- Yahoo
C-suite access is the new divide in the hedge fund world
Corporate access has become the latest institutional shift for the largest hedge funds in the industry. The biggest firms have teams of people handling their relationships with companies and get the most access. Citadel, for example, does more than 30,000 meetings with executives a year. You can't buy time, but hedge funds are trying. Some of the most valuable time in the world is that of a CEO of a large public company like Jamie Dimon or Mark Zuckerberg, whose days are planned to the millisecond. They carve out time to speak to their companies' investors about strategy, expectations, and more, and it's those seconds that the biggest hedge funds in the world are increasingly monopolizing. Multistrategy giants like Izzy Englander's Millennium, Ken Griffin's Citadel, Steve Cohen's Point72, and Dmitry Balyasny's eponymous firm operate with dozens — sometimes hundreds — of investment teams under one roof, each running their own strategy. These firms' stock-picking teams compete with each other and rivals for face time with leaders at the world's biggest companies. In conversations with 15 portfolio managers, hedge fund executives, bankers, corporate access professionals, and investor relations heads, Business Insider found that access to C-suites — once a more level playing field — has become another area where the biggest firms dominate. The process is now a source of growing tension as smaller investment firms get edged out, companies are flooded with requests, and even top firms grapple with internal strains over who gets into the boardroom. A decade ago, the connection between these firms and corporations was run solely through brokers working at investment banks, also known as the sell-side. Now, while the sell-side has not been cut out of the equation, the biggest hedge funds employ large teams of corporate access pros themselves, with personnel based in the US, Europe, and Asia helping mega funds get their ever-growing investing team members face time with CEOs. Citadel boasts on its website that it does more than 30,000 meetings with corporate executives each year. Millennium's increasing allocation to externally run funds means more wallets to pay the sell-side, ensuring better access and preferential treatment from brokers. Balyasny has done educational events for corporate investor relations teams in Asia, India, and the US in the last 12 months to explain the firm's structure and introduce its broker relations leaders. Funds mentioned in this story declined to comment. "A big part of the job is keeping everyone happy," said one hedge fund executive who has managed stock-picking teams for more than a decade. 'Kids' table' Twenty-seven-year-olds in T-shirts. Cameras off during pandemic-era Zooms. Typing on laptops or phones while CEOs spoke. Twenty people on a call, all vying to ask a hyperspecific question, often related to next quarter's earnings. Companies, especially the largest ones with the busiest executives, were getting frustrated as the headcounts of the industry's elite swelled, according to two corporate investor relations executives. At bank-held conferences, alongside tenured portfolio managers from long-only funds and asset management giants like Fidelity and Wellington, "we were always the kids' table," one multistrategy executive admitted. It was "pretty common" between 2018 and 2021 for executives to say no to meeting with some of these firms, or sharply curtailing the number of seats allotted to these funds, said Christopher Melito, a former corporate access pro at Cowen, Citi, and Credit Suisse. Even with how much these firms paid the sell-side, "at the end of the day, a C-suite could say 'don't confirm that request, we aren't meeting with them,'" said Melito, who is now the head of investor access at consulting firm ICR. Though the industry started building corporate access teams as early as 2015, it took years for teams to get to their current efficiency. One early hire industry experts pointed to was when Citadel promoted Johnna Shields to the role of corporate relations manager within its Global Equities stockpicking unit. Now, these staffers play a critical role in smoothing the path for hedge funds, which aren't always trusted by CEOs who worry about potential short-sellers and capital that'll leave at the first sign of trouble. Similar to the growing importance of the business development role, those in corporate access have become a key cog within multistrategy firms, despite the fact that they don't manage capital themselves. Jain Global, for example, brought on Katie Vogt, a former Balyasny and Goldman Sachs staffer, to head its corporate access efforts, deeming the function important enough to hire someone pre-launch. There's now a much healthier two-way street between funds and corporates. For example, "a lot of top four funds stopped putting junior members in these meetings," Melito said, and started training younger investment team members on protocol. One former PM said that at Point72, blazers are required when meeting with an executive. At other large firms, Melito said, young analysts start by meeting with smaller-cap companies before shadowing more senior investors in meetings with large-cap corporations. Corporate access teams have shifted from booking agents to matchmakers, one person close to a big four fund said, pairing different teams and investors with the right executives. "The large four funds have been a lot more strategic about their asks," Melito said. Everything's political Although the relationships between funds and companies may be solid, there is still plenty of bickering internally at the asset managers. One portfolio manager at a large firm said the biggest fights he ever saw were between two teams wanting access to the same executive — and there would only be room for one. Firms often give more tenured teams the right of first refusal for a meeting, but sometimes big-name new hires will jump the line, causing a rift, another PM said. All jobs have an element of internal politics to them, but in the cutthroat hedge-fund world, where a right call could mean a life-changing annual bonus and a wrong call could mean a pink slip, the stakes are magnified. The growing staff at the biggest managers means that a potential meeting with a Fortune 500 CEO will have plenty of interested parties. At Citadel alone, there are roughly 300 stockpickers, Griffin said at a talk at his former high school in Florida earlier this year. While the biggest funds can offer eye-popping sign-on bonuses and larger books of capital to manage, smaller funds that haven't been able to keep up with the big boys on corporate access resources are leveraging the internal tiffs to help their recruiting. "We can say 'You're our tech guy,' and while we can't compete on upfront guarantees, we can give them better long-term incentives," said one individual who runs a smaller multistrategy firm. These incentives include automatic IPO distributions, he said, which can be hard to come by if you're lower down the totem pole in one of the bigger firms. In the ongoing war for talent that has top moneymakers getting offers of tens of millions of dollars in total potential compensation, an important question for candidates is how many other teams trade their specialty or sector, one recruiter said. "It's a make-or-break kind of question," he said. No one wants to be one of 20 investing in technology companies "unless the money's just stupid," he added. Is it 'something AI could do' or a differentiator? The reason these firms have been able to build up these teams and pay out such large commissions to the Street is because of the pass-through fee agreements that put their backers on the hook for business costs. The question limited partners need to ask: Is it worth it? Several PMs at firms with large corporate access teams told Business Insider they could do without. One European equity investor said CEOs have become more scripted than ever, so meetings are basically a rerun of what they've previously said on earnings calls or at conferences. Another, based in the US, said the biggest value from these meetings used to be a sentiment check on how other teams were thinking about the stock — but now questions are often too specific and narrow to give any kind of indication into their thinking. For one founder of a smaller activism fund, the meetings are a prime example of something that firms could eventually save money on by automating away. "All these young analysts are asking questions off a sheet of paper their PM gave them and then typing into their models right there," the activist said. "It's something AI could do." It's hard to quantify how much a 30-minute conversation with a CFO is worth to a fund's bottom line. One industry consultant believes the push for funds to adopt cash hurdles — which would require their net returns to be over that of a Treasury bond to earn performance fees — might lead to some firms cutting costs in different places, including payments to the sell-side. Still, longtime stockpickers appreciate time with executives, and the old guard believes there's value in it. Tiger Global's billionaire founder, Chase Coleman, sees merit in these meetings and still attends them, a person close to the firm said, and funds have brought in former CIA interrogators to help investors dissect body language and read between the lines of a prepared statement. Even beyond the informational advantages mega funds can glean from these meetings, corporate access is also a zero-sum game. The more meeting slots and conference registrations the industry's largest firms take up, the fewer everyone else can get. "It's a finite resource," said one sell-side broker. "They don't want to share." Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data